Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of BRCA in Patients With Primary or Platinum Sensitive Recurrent Ovarian Cancer.

NCT02222883 is registered in ClinicalTrials.gov with AGO Research GmbH as lead sponsor.

NCT NCT02222883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of BRCA in Patients With Primary or Platinum Sensitive Recurrent Ovarian Cancer.
Lead sponsor
AGO Research GmbH
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
April 1, 2021
Enrollment
530 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

brca status, ovarian cancer